Abstracts tagged "health disparities and methotrexate (MTX)"

Abstract Number: 224 • ACR/ARHP Annual Meeting 2017
Patterns of Methotrexate Use in African Countries with Low Versus Medium/High Human Development Index: Preliminary Results of Semi-Structured Interviews
Carol A Hitchon¹, Yan Liu², Steven Shi³, Girish M Mody⁴, Candace H. Feldman⁵, Michael Weinblatt⁶ and Ines Colmegna⁷, ¹Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, ²McGill University, Montreal, QC, Canada, ³University de Montreal, Montreal, QC, Canada, ⁴Dept of Rheumatology, University of Kwa Zulu-Natal, Durban, South Africa, ⁵Brigham and Women’s Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, ⁶Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁷Division of Rheumatology, Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada
Background/Purpose: Methotrexate (MTX) is standard therapy for rheumatoid arthritis (RA) and also used to treat other rheumatic diseases. Existing guidelines for RA treatment/ MTX use…